D-Index & Metrics Best Publications
Research.com 2022 Best Scientist Award Badge

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 158 Citations 155,732 1,143 World Ranking 306 National Ranking 196
Best Scientists D-index 158 Citations 155,892 1,356 World Ranking 886 National Ranking 565

Research.com Recognitions

Awards & Achievements

2022 - Research.com Best Scientist Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Heart failure
  • Cardiology

John G.F. Cleland mainly focuses on Heart failure, Internal medicine, Cardiology, Ejection fraction and Heart disease. John G.F. Cleland has researched Heart failure in several fields, including Surgery, Blood pressure, Intensive care medicine, Myocardial infarction and Atrial fibrillation. His research on Internal medicine often connects related topics like Endocrinology.

His research in Cardiology focuses on subjects like Hazard ratio, which are connected to Proportional hazards model. His Ejection fraction study combines topics in areas such as Interquartile range, Intention-to-treat analysis, Clinical endpoint, Ventricular remodeling and Pulmonary wedge pressure. His research integrates issues of Anesthesia, Rolofylline, Cardiomyopathy, Circulatory system and Micronutrient in his study of Heart disease.

His most cited work include:

  • 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. (9345 citations)
  • 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (6276 citations)
  • The effect of cardiac resynchronization on morbidity and mortality in heart failure (5119 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Heart failure, Internal medicine, Cardiology, Ejection fraction and Intensive care medicine. His Heart failure research is multidisciplinary, relying on both Heart disease, Randomized controlled trial, Atrial fibrillation and Clinical trial. His study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology and Surgery.

His work in Cardiac resynchronization therapy, Coronary artery disease, Carvedilol, Sinus rhythm and Stroke volume are all subfields of Cardiology research. His biological study spans a wide range of topics, including Natriuretic peptide and Interquartile range. The various areas that John G.F. Cleland examines in his Intensive care medicine study include Disease and MEDLINE.

He most often published in these fields:

  • Heart failure (91.32%)
  • Internal medicine (82.56%)
  • Cardiology (66.12%)

What were the highlights of his more recent work (between 2018-2021)?

  • Heart failure (91.32%)
  • Internal medicine (82.56%)
  • Cardiology (66.12%)

In recent papers he was focusing on the following fields of study:

John G.F. Cleland focuses on Heart failure, Internal medicine, Cardiology, Ejection fraction and In patient. His work carried out in the field of Heart failure brings together such families of science as Blood pressure, Clinical endpoint, Cohort and Atrial fibrillation. His research in Atrial fibrillation intersects with topics in Text mining and MEDLINE.

His studies in Hazard ratio, Confidence interval, Coronary artery disease, Interquartile range and Clinical trial are all subfields of Internal medicine research. His study in Sinus rhythm, Myocardial infarction, Stroke volume, Heart failure with preserved ejection fraction and Rivaroxaban falls under the purview of Cardiology. His research investigates the connection between Ejection fraction and topics such as Omecamtiv mecarbil that intersect with issues in Cardiac function curve.

Between 2018 and 2021, his most popular works were:

  • Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction (419 citations)
  • Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology (218 citations)
  • Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology (218 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Heart failure
  • Disease

John G.F. Cleland spends much of his time researching Heart failure, Internal medicine, Cardiology, Ejection fraction and Hazard ratio. His Heart failure study combines topics from a wide range of disciplines, such as Clinical trial and Intensive care medicine. His Internal medicine research focuses on Coronary artery disease, Cohort, Confidence interval, Randomized controlled trial and Disease.

His study in Atrial fibrillation, Rivaroxaban, Sinus rhythm, Myocardial infarction and Cardiac function curve is carried out as part of his studies in Cardiology. His Ejection fraction research is multidisciplinary, incorporating perspectives in Interquartile range, Cohort study, Transferrin saturation, Management of heart failure and Prospective cohort study. His research integrates issues of Body mass index and Gastroenterology in his study of Hazard ratio.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Piotr Ponikowski;Adriaan A. Voors;Stefan D. Anker;Héctor Bueno.
European Journal of Heart Failure (2016)

19435 Citations

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Piotr Ponikowski;Adriaan A Voors;Stefan D Anker;Héctor Bueno.
European Heart Journal (2016)

11742 Citations

The effect of cardiac resynchronization on morbidity and mortality in heart failure

John G.F. Cleland;Jean-Claude Daubert;Erland Erdmann;Nick Freemantle.
web science (2005)

8325 Citations

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

Karl Swedberg;John Cleland;Henry Dargie;Helmut Drexler.
European Heart Journal (2005)

4282 Citations

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy : The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)

Michele Brignole;Angelo Auricchio;Gonzalo Baron-Esquivias;Pierre Bordachar.
European Heart Journal (2013)

3361 Citations

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

Philip A. Poole-Wilson;Karl Swedberg;John G.F. Cleland;Andrea Di Lenarda.
The Lancet (2003)

2485 Citations

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.

J.G.F Cleland;K Swedberg;F Follath;M Komajda.
European Heart Journal (2003)

1938 Citations

beta Blockade after myocardial infarction: systematic review and meta regression analysis.

Nick Freemantle;John Cleland;Philip Young;James Mason.
BMJ (1999)

1913 Citations

Rosuvastatin in Older Patients with Systolic Heart Failure

John Kjekshus;Eduard Apetrei;Vivencio Barrios;Michael Böhm.
The New England Journal of Medicine (2007)

1814 Citations

The perindopril in elderly people with chronic heart failure (PEP-CHF) study

John G.F. Cleland;Michal Tendera;Jerzy Adamus;Nick Freemantle.
European Heart Journal (2006)

1594 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing John G.F. Cleland

John J.V. McMurray

John J.V. McMurray

University of Glasgow

Publications: 472

Gregg C. Fonarow

Gregg C. Fonarow

University of California, Los Angeles

Publications: 341

Marco Metra

Marco Metra

University of Brescia

Publications: 340

Mihai Gheorghiade

Mihai Gheorghiade

Northwestern University

Publications: 328

Scott D. Solomon

Scott D. Solomon

Brigham and Women's Hospital

Publications: 313

Gerasimos Filippatos

Gerasimos Filippatos

National and Kapodistrian University of Athens

Publications: 292

Alexandre Mebazaa

Alexandre Mebazaa

Université Paris Cité

Publications: 287

Javed Butler

Javed Butler

University of Mississippi

Publications: 286

Dirk J. van Veldhuisen

Dirk J. van Veldhuisen

University Medical Center Groningen

Publications: 286

Adriaan A. Voors

Adriaan A. Voors

University Medical Center Groningen

Publications: 282

Karl Swedberg

Karl Swedberg

University of Gothenburg

Publications: 280

Faiez Zannad

Faiez Zannad

University of Lorraine

Publications: 273

Piotr Ponikowski

Piotr Ponikowski

Wrocław Medical University

Publications: 266

Christopher M. O'Connor

Christopher M. O'Connor

Duke University

Publications: 248

Aldo P. Maggioni

Aldo P. Maggioni

Heart Care Foundation, ANMCO Research Center, Florence

Publications: 245

Gregory Y.H. Lip

Gregory Y.H. Lip

University of Liverpool

Publications: 236

Trending Scientists

Mitchell Luskin

Mitchell Luskin

University of Minnesota

Charles H. Dennison

Charles H. Dennison

Intel (United States)

Julio F. Davalos

Julio F. Davalos

City College of New York

Daniel Taton

Daniel Taton

University of Bordeaux

Keith Moffat

Keith Moffat

University of Chicago

Keith Reid

Keith Reid

Natural Environment Research Council

Markus A. Rüegg

Markus A. Rüegg

University of Basel

Jeremy Nathans

Jeremy Nathans

Johns Hopkins University School of Medicine

Denis Curtin

Denis Curtin

Plant & Food Research

Kevin Walsh

Kevin Walsh

University of Melbourne

Willem Bouten

Willem Bouten

University of Amsterdam

Patrick G. J. Irwin

Patrick G. J. Irwin

University of Oxford

Inakwu O. A. Odeh

Inakwu O. A. Odeh

University of Sydney

Evgeny A. Budygin

Evgeny A. Budygin

Wake Forest University

Marinus J.C. Eijkemans

Marinus J.C. Eijkemans

Utrecht University

Garnet L. Anderson

Garnet L. Anderson

Fred Hutchinson Cancer Research Center

Something went wrong. Please try again later.